Immune dysregulation in bone marrow failure syndromes: implications for pathogenesis and clonal evolution.

    Project: Research

    Project Details

    StatusFinished
    Effective start/end date1/10/201028/02/2021

    Collaborative partners

    • King's College London (lead)
    • KCH King's College Hospital NHS Foundation Trust
    • CRUK Cancer Research UK
    • Celgene Corporation

    Funding

    • Blood Cancer UK: £1,500.00
    • Blood Cancer UK: £848,554.00
    • Blood Cancer UK: £1,677,358.00